Status Purchase has not taken place
Estimated value without VAT 122,74 MDL
Period of clarifications: 13 Jul 2022, 17:30 - 18 Jul 2022, 9:00
Submission of proposals: 18 Jul 2022, 9:00 - 21 Jul 2022, 11:00
Auction start date: 22 Jul 2022, 12:55

Supplier technical support:

(+373) 79999801

Doxycyclinum 100 mg
Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Full name
Macari Doina
Contact phone
+37322222490
Purchase data
Date created
Date modified
13 Jul 2022, 17:30
Estimated value (without VAT)
122,74 MDL
The minimum downward of the price
1 MDL
Achizitii.md ID
21059963
Type of procedure
Request price offers (goods)
Award criteria
The lowest price
Delivery address
MD-2009, MOLDOVA, mun.Chişinău, mun.Chişinău, IMSP Spitalul Clinic de Boli Infecțioase “Toma Ciorbă”
Contract period
29 Jul 2022 03:00 - 31 Dec 2022 02:00
List of positions
1)
Title
Doxycyclinum 100 mg CPV: 33600000-6 - Pharmaceutical products
Quantity: 100.0
Unit of measurement: Bucata
Documents of the procurement procedure
DUAE Model
Bidding Documents
Duae model
13.07.22 17:30
Anunt de participare1.semnat
Bidding Documents
Anunț de participare
13.07.22 17:30
Scrisoare de garantie bancara_Model
Bidding Documents
Scrisoare Oe
13.07.22 17:30
Documentatia standard.semnat
Bidding Documents
Documentația standard
13.07.22 17:30
Cerere de participare_Model
Bidding Documents
Cerere de participare
13.07.22 17:30
Declaratie beneficiari efectivi_Model
Bidding Documents
Declarație OE
13.07.22 17:30
Propunerea tehnica (Specificatii tehnice)_Model
Technical Specifications
Propunerea financiară
13.07.22 17:30
Contract model
Bidding Documents
Contract model
13.07.22 17:30
Declaratie privind valabilitatea ofertei_Model
Bidding Documents
Declarație OE
13.07.22 17:30
Propunerea financiara modificata
Technical Specifications
Propunerea financiară
13.07.22 17:30
The history of the auction
View auction
Unfortunately, questions can be asked only during the "Active" period.
Clarifications